NASDAQ:COLL
$21.63
(
-3.22%
)
Friday, 2nd Jun 2023
Collegium Pharmaceutical Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $21.08 | $24.17 | Friday, 2nd Jun 2023 COLL stock ended at $21.63. This is 3.22% less than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 7.14% from a day low at $21.08 to a day high of $22.59. |
| 90 days | $21.08 | $27.03 | |
| 52 weeks | $15.10 | $30.22 |
Historical Collegium Pharmaceutical prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $22.45 | $22.59 | $21.08 | $21.63 | 412 741 |
| 2023-06-01 | $22.00 | $22.64 | $21.81 | $22.35 | 253 646 |
| 2023-05-31 | $21.73 | $22.77 | $21.61 | $22.07 | 259 291 |
| 2023-05-30 | $22.61 | $22.96 | $21.60 | $21.80 | 221 001 |
| 2023-05-26 | $22.42 | $22.74 | $22.25 | $22.53 | 154 139 |
| 2023-05-25 | $22.95 | $22.99 | $22.18 | $22.38 | 223 194 |
| 2023-05-24 | $23.14 | $23.14 | $22.74 | $23.04 | 166 192 |
| 2023-05-23 | $23.50 | $24.17 | $23.19 | $23.25 | 228 384 |
| 2023-05-22 | $23.31 | $23.62 | $23.27 | $23.51 | 171 511 |
| 2023-05-19 | $22.77 | $23.28 | $22.75 | $23.27 | 229 493 |
| 2023-05-18 | $22.73 | $22.86 | $22.33 | $22.53 | 244 583 |
| 2023-05-17 | $23.11 | $23.13 | $22.69 | $22.83 | 199 026 |
| 2023-05-16 | $23.37 | $23.37 | $22.84 | $23.03 | 256 033 |
| 2023-05-15 | $23.11 | $23.63 | $23.11 | $23.50 | 245 083 |
| 2023-05-12 | $23.25 | $23.25 | $22.85 | $23.07 | 254 566 |
| 2023-05-11 | $23.00 | $23.24 | $22.86 | $23.13 | 291 638 |
| 2023-05-10 | $23.77 | $23.77 | $22.72 | $23.09 | 303 913 |
| 2023-05-09 | $23.43 | $23.67 | $23.10 | $23.53 | 424 989 |
| 2023-05-08 | $23.02 | $23.52 | $22.75 | $23.42 | 397 036 |
| 2023-05-05 | $22.49 | $23.43 | $22.00 | $22.91 | 701 953 |
| 2023-05-04 | $22.05 | $22.41 | $21.70 | $22.20 | 560 358 |
| 2023-05-03 | $22.35 | $22.63 | $21.50 | $22.11 | 567 663 |
| 2023-05-02 | $22.86 | $23.12 | $21.79 | $22.30 | 566 429 |
| 2023-05-01 | $22.98 | $23.54 | $22.73 | $22.99 | 563 443 |
| 2023-04-28 | $22.94 | $23.48 | $22.95 | $23.27 | 345 017 |
| 2023-04-27 | $23.08 | $23.29 | $22.72 | $23.18 | 197 873 |
| 2023-04-26 | $22.70 | $22.90 | $22.55 | $22.84 | 140 214 |
| 2023-04-25 | $23.10 | $23.14 | $22.41 | $22.78 | 537 571 |
| 2023-04-24 | $22.98 | $23.49 | $22.91 | $23.40 | 303 320 |
| 2023-04-21 | $22.83 | $23.36 | $22.67 | $23.07 | 267 744 |
| 2023-04-20 | $22.80 | $23.19 | $22.67 | $22.84 | 287 665 |
| 2023-04-19 | $23.13 | $23.25 | $22.66 | $22.88 | 235 797 |
| 2023-04-18 | $23.21 | $23.26 | $23.05 | $23.14 | 231 322 |
| 2023-04-17 | $23.08 | $23.37 | $22.52 | $23.17 | 191 108 |
| 2023-04-14 | $22.92 | $23.33 | $22.62 | $22.93 | 214 199 |
| 2023-04-13 | $22.47 | $23.30 | $22.47 | $23.00 | 408 454 |
| 2023-04-12 | $23.72 | $23.84 | $21.99 | $22.08 | 604 355 |
| 2023-04-11 | $23.93 | $24.00 | $23.48 | $23.55 | 716 925 |
| 2023-04-10 | $23.42 | $23.90 | $23.29 | $23.67 | 346 004 |
| 2023-04-06 | $23.66 | $23.74 | $23.37 | $23.49 | 283 165 |
| 2023-04-05 | $24.05 | $24.10 | $23.22 | $23.50 | 332 195 |
| 2023-04-04 | $23.92 | $24.03 | $23.34 | $24.00 | 248 811 |
| 2023-04-03 | $23.98 | $24.08 | $23.56 | $23.69 | 286 189 |
| 2023-03-31 | $24.55 | $25.00 | $23.95 | $23.99 | 353 807 |
| 2023-03-30 | $23.88 | $24.40 | $23.88 | $24.37 | 154 391 |
| 2023-03-29 | $24.44 | $24.44 | $23.82 | $24.00 | 233 360 |
| 2023-03-28 | $24.09 | $24.37 | $23.25 | $24.17 | 164 165 |
| 2023-03-27 | $24.09 | $24.29 | $22.92 | $24.15 | 171 684 |
| 2023-03-24 | $22.82 | $23.99 | $22.67 | $23.77 | 424 333 |
| 2023-03-23 | $24.30 | $24.30 | $22.93 | $23.00 | 324 508 |
About Collegium Pharmaceutical
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm... COLL Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
